including ‘smart’ injectors and inhalers. Novo Nordisk is in talks with Bio Jag – Biocorp’s main shareholder – to buy its entire stake in the company at a price of €35 per share ...

Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

Novo Nordisk shares gained Monday as the company said it would present new data on the ability of semaglutide, the active ingredient in its weight-loss drugs Ozempic and Wegovy, to lower heart risks.